Pennsaid
NDC Package 69451-300-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pennsaid is a medication used to treat arthritis of the knee(s). Marketed by Nuvo Pharmaceuticals Inc., this product is identified by NDC 69451-300 and is authorized under FDA application NDA020947.

Identification & Billing

NDC Package Code
69451-300-15
Package Description
1 BOTTLE, DROPPER in 1 CARTON / 160.5 g in 1 BOTTLE, DROPPER
Product Code
69451-300
11-Digit Billing Format
69451030015

Clinical Specifications

Proprietary Name
Pennsaid
Dosage Form
-
Usage Information
This medication is used to treat arthritis of the knee(s). It reduces pain and swelling, and helps improve your ability to move and flex the joint. Diclofenac is known as a nonsteroidal anti-inflammatory drug (NSAID).

Regulatory & Marketing

Labeler Name
Nuvo Pharmaceuticals Inc.
FDA Application #
NDA020947
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-24-2010
End Marketing Date
02-29-2016
Listing Expiration
02-29-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69451-300-15 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 160.5 g in 1 bottle, dropper of Pennsaid, labeled by Nuvo Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nuvo Pharmaceuticals Inc. on April 24, 2010. The current certification is valid through February 29, 2016.

What are the primary indications for this medication?

This medication is used to treat arthritis of the knee(s). It reduces pain and swelling, and helps improve your ability to move and flex the joint. Diclofenac is known as a nonsteroidal anti-inflammatory drug (NSAID).

How is this Nuvo Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69451030015. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69451-300-15
11-Digit CMS (5-4-2)
69451-0300-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.